Erik De Clercq introducing John C. Martin for an Honorary Doctorate
Medical Faculty in Leuven, Belgium September 13, 2017
Erik De Clercq and Antonin Holy
Antonin Holy and Erik De Clercq became co-inventors of a key class of antiviral drugs a.o. Tenofovir to combat the HIV virus
Lineup of key pharmaceuticals
Products resulting from the Holý-De Clercq collaboration and commercialized by Gilead (photo courtesy Gilead Sciences, Inc.)
Erik De Clercq introducing John C. Martin for an Honorary Doctorate
Medical Faculty in Leuven, Belgium September 13, 2017
1/7
Erik De Clercq M.D. Ph.D.
